Sitagliptin 50 mg + Metformin 1000 mg + Glimepiride 2 mg Tablet – Brands in India (Sitawise-MG)
Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: DPP-4 inhibitor combination
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Sitagliptin + Metformin + Glimepiride – Brands in India for PCD Franchise & Wholesale
Looking for sitagliptin metformin glimepiride brands in India? Trumac Healthcare markets the triple combination as Sitawise-MG 50/1000/2 and Sitawise-MG 50/1000/1 (sitagliptin 50 mg + metformin 1000 mg SR + glimepiride 2 mg or 1 mg, 10 x 10 alu-alu), made at WHO-GMP certified partner units, on a monopoly PCD franchise basis and as wholesale stock across India. The three-drug tablet is a common step-up when metformin and a sulfonylurea no longer control HbA1c.
It is part of the cardiac-diabetic PCD franchise (Ecron Life Sciences) range with the Sitawise, Vildafact, Linaglite and Emparon families. Trumac Healthcare has worked since 2007 and supplies more than 4000 franchise partners; no franchise fee, minimum first order ₹25,000.
Sitagliptin brands
- Sitawise-MG 50/1000/2 – sitagliptin + metformin SR + glimepiride 2 mg, 10 x 10 alu-alu
- Sitawise-MG 50/1000/1 – with glimepiride 1 mg
- Emparon-S 25/100 – empagliflozin + sitagliptin
- Linaglite-DM – linagliptin + dapagliflozin + metformin
- Full range: cardiac-diabetic PCD franchise (Ecron Life Sciences)
Ways to work with us
- PCD pharma franchise – sitagliptin + metformin + glimepiride tablets under our brand on a monopoly basis for your area, with visual aids and promotional material
- Wholesale supply – stock for distributors, stockists and hospital suppliers across India, against drug licence and GST
- Own-brand (third-party) enquiries – share the composition, pack and quantity and we will confirm availability and send a quotation
How to start
- Send your requirement on WhatsApp – product, franchise or wholesale, quantity and your area
- Receive the price list and monopoly terms (no franchise fee; minimum first order ₹25,000)
- Confirm the order and pay by NEFT, RTGS or IMPS
- Goods are dispatched once payment reflects, with the docket number for tracking
Questions buyers ask
Which sitagliptin + metformin + glimepiride brands are available in India for PCD franchise?
Sitawise-MG 50/1000/2 and 50/1000/1 from Trumac Healthcare, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis across India.
Do you supply the triple combination wholesale?
Yes, to distributors and stockists with a valid drug licence. Share quantity and location for the rate.
Which glimepiride strengths are available?
1 mg and 2 mg, both with sitagliptin 50 mg and metformin 1000 mg sustained release.
Is it part of the cardiac-diabetic monopoly?
Yes – the cardiac-diabetic division (Ecron Life Sciences) can be taken alone for your district.
Enquiry: Share your sitagliptin combination requirement – franchise or wholesale, with strength, quantity and location. WhatsApp +91 90416 77932.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the general range products product list. No franchise fee; minimum first order ₹25,000 – cost and documents.
Therapeutic Indications
- Type-2 diabetes mellitus
- Add-on therapy in inadequate control
- Glycaemic intensification
- Patients needing weight-neutral therapy
Mechanism of Action
Sitagliptin selectively inhibits DPP-4, prolonging the action of incretin hormones GLP-1 and GIP. This increases glucose-dependent insulin secretion and suppresses glucagon, providing glycaemic control without hypoglycaemia in non-eugenic states. Weight-neutral, well-tolerated profile. Glimepiride 2 mg provides higher sulphonylurea-mediated insulin secretion stimulation.
Dosage & Administration
- Adults: 1 tablet once daily (or twice for some FDCs)
- Take with or without food
- Adjust dose in renal impairment
- Monitor renal function and HbA1c periodically
Side Effects
- Nasopharyngitis
- Headache
- Hypoglycaemia (with SU/insulin)
- Pancreatitis (rare)
- Joint pain
- GI upset (with metformin component)
Contraindications
- Type-1 diabetes
- Diabetic ketoacidosis
- Severe renal impairment (with metformin)
- History of severe pancreatitis
- Pregnancy and breastfeeding
Storage
Store below 25°C.
PCD Pharma Franchise for Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet?
Available pack sizes include: 10 x 10 (Alu Alu).
What is the MRP / trade price for Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet?
MRPs range from ₹1680 to ₹1680 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Sitagliptin 50 mg + Metformin 1000 mg (SR) + Glimepiride 2 mg Tablet?
